These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3708036)

  • 21. High levels of plasma catecholamines in dexamethasone-resistant depressed patients.
    Barnes RF; Veith RC; Borson S; Verhey J; Raskind MA; Halter JB
    Am J Psychiatry; 1983 Dec; 140(12):1623-5. PubMed ID: 6650697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia.
    Jakovljević M; Mück-Seler D; Pivac N; Crncević Z
    Neuropsychobiology; 1998; 37(3):142-5. PubMed ID: 9597670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
    Poland RE; Rubin RT; Lesser IM; Lane LA; Hart PJ
    Arch Gen Psychiatry; 1987 Sep; 44(9):790-5. PubMed ID: 3632252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexamethasone suppression test in schizophrenia: its relation to monoamine metabolism in hypothalamic-pituitary-adrenal axis.
    Kaneko M; Murata S; Hoshino Y; Takahagi K; Yokoyama F; Watanabe M; Kumashiro H
    Neuropsychobiology; 1990-1991; 24(1):12-6. PubMed ID: 2132636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive impairment and cortisol resistance to dexamethasone suppression in elderly depression.
    Siegel B; Gurevich D; Oxenkrug GF
    Biol Psychiatry; 1989 Jan; 25(2):229-34. PubMed ID: 2930804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexamethasone suppression test in schizophrenia. A study and review.
    Asnis GM; Eisenberg J; Lemus CZ; Halbreich U
    Neuropsychobiology; 1986; 15(3-4):109-13. PubMed ID: 3785640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dexamethasone suppression test in schizo-affective depression.
    Katona CL; Roth M
    J Affect Disord; 1985; 8(2):107-12. PubMed ID: 3157718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circadian rhythm of vital signs, norepinephrine, epinephrine, thyroid hormones, and cortisol in schizophrenia.
    Rao ML; Strebel B; Halaris A; Gross G; Bräunig P; Huber G; Marler M
    Psychiatry Res; 1995 Jun; 57(1):21-39. PubMed ID: 7568556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nocturnal melatonin and cortisol secretion in newly admitted psychiatric inpatients. Implications for affective disorders.
    Steiner M; Brown GM; Goldman S
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(1):21-7. PubMed ID: 2147898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of the dexamethasone test in the differential diagnosis of depressive states].
    Nuller IuL; Ostroumova MN; Gordon OI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):547-51. PubMed ID: 3716705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D; Addington J
    Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence of abnormal dexamethasone suppression in schizophrenia: a review and a meta-analytic comparison with the incidence in normal controls.
    Yeragani VK
    Can J Psychiatry; 1990 Mar; 35(2):128-32. PubMed ID: 2138504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dexamethasone suppression test in adolescent psychiatric inpatients.
    Targum SD; Capodanno AE
    Am J Psychiatry; 1983 May; 140(5):589-91. PubMed ID: 6846588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
    Lammers CH; Garcia-Borreguero D; Schmider J; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
    Biol Psychiatry; 1995 Dec; 38(12):803-7. PubMed ID: 8750038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexamethasone suppression test and suicide attempts in schizophrenic patients.
    Płocka-Lewandowska M; Araszkiewicz A; Rybakowski JK
    Eur Psychiatry; 2001 Nov; 16(7):428-31. PubMed ID: 11728857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis activity in schizophrenic patients with positive and negative symptoms.
    Pivac N; Mück-Seler D; Jakovljević M
    Neuropsychobiology; 1997; 36(1):19-21. PubMed ID: 9211439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dexamethasone suppression index: enhancement of DST diagnostic utility for depression by expressing serum cortisol as a function of serum dexamethasone.
    Arana GW; Reichlin S; Workman R; Haaser R; Shader RI
    Am J Psychiatry; 1988 Jun; 145(6):707-11. PubMed ID: 3369557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contributions of cortisol suppression tests to understanding of psychiatric disorders: a narrative review of literature].
    Tajima-Pozo K; Montes-Montero A; Güemes I; González-Vives S; Díaz-Marsá M; Carrasco JL
    Endocrinol Nutr; 2013; 60(7):396-403. PubMed ID: 23623464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexamethasone concentrations and the dexamethasone suppression test in psychiatric disorders.
    Morris H; Carr V; Gilliland J; Hooper M
    Br J Psychiatry; 1986 Jan; 148():66-9. PubMed ID: 3955321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.